Discontinued — last reported Q4 '23
Business Segments · Other Depreciation and Amortization
CarelonRx Segment — Other Depreciation and Amortization
This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2021
Last reportedQ4 2023Feb 21, 2024
Rolls up toOther Depreciation and Amortization
How to read this metric
Consistent levels indicate steady capital investment, while sudden spikes may reflect accelerated write-offs of technology assets.
Detailed definition
This represents the allocation of the cost of tangible and intangible assets (excluding standard depreciation) over thei...
Peer comparison
Standard 'Depreciation and Amortization' line item found in segment-level operating performance reports.
Metric ID:
elv_segment_carelonrx_segment_other_depreciation_and_amortizationHistorical Data
3 years
| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 |
Range$0.00 – $0.00
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Elevance Health's carelonrx segment — other depreciation and amortization?
- Elevance Health (ELV) reported carelonrx segment — other depreciation and amortization of $0.00 in Q4 2023.
- What does carelonrx segment — other depreciation and amortization mean?
- The non-cash expense of using up long-term assets in the pharmacy services business.